Back to top

rsi: Archive

Zacks Equity Research

Down -23.15% in 4 Weeks, Here's Why Crescent Energy (CRGY) Looks Ripe for a Turnaround

Crescent Energy (CRGY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CRGYPositive Net Change

Zacks Equity Research

Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Third Harmonic Bio, Inc. (THRD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

THRDPositive Net Change

Zacks Equity Research

Down -18.02% in 4 Weeks, Here's Why Strategic Education (STRA) Looks Ripe for a Turnaround

Strategic Education (STRA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

STRAPositive Net Change

Zacks Equity Research

Down -18.44% in 4 Weeks, Here's Why You Should You Buy the Dip in Under Armour (UAA)

Under Armour (UAA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

UAAPositive Net Change

Zacks Equity Research

C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

C4 Therapeutics (CCCC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CCCCPositive Net Change

Zacks Equity Research

After Plunging -13.4% in 4 Weeks, Here's Why the Trend Might Reverse for Maximus (MMS)

The heavy selling pressure might have exhausted for Maximus (MMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MMSPositive Net Change

Zacks Equity Research

Down -28.09% in 4 Weeks, Here's Why Hyliion (HYLN) Looks Ripe for a Turnaround

Hyliion (HYLN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

HYLNPositive Net Change

Zacks Equity Research

After Plunging -17.28% in 4 Weeks, Here's Why the Trend Might Reverse for Crescent Energy (CRGY)

Crescent Energy (CRGY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CRGYPositive Net Change

Zacks Equity Research

American Airlines (AAL) Loses -14.02% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

American Airlines (AAL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

AALPositive Net Change

Zacks Equity Research

Here's Why Raymond James Financial (RJF) is Poised for a Turnaround After Losing -11.09% in 4 Weeks

Raymond James Financial (RJF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

RJFPositive Net Change

Zacks Equity Research

Marvell (MRVL) Loses -20.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Marvell (MRVL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MRVLPositive Net Change

Zacks Equity Research

Down -28.61% in 4 Weeks, Here's Why You Should You Buy the Dip in indie Semiconductor (INDI)

The heavy selling pressure might have exhausted for indie Semiconductor (INDI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

INDIPositive Net Change

Zacks Equity Research

C4 Therapeutics (CCCC) Loses -26.18% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for C4 Therapeutics (CCCC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CCCCPositive Net Change

Zacks Equity Research

Down -13.15% in 4 Weeks, Here's Why You Should You Buy the Dip in Synchrony (SYF)

The heavy selling pressure might have exhausted for Synchrony (SYF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SYFPositive Net Change

Zacks Equity Research

Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround

Artivion (AORT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

AORTNo Net Change

Zacks Equity Research

Here's Why Raymond James Financial (RJF) is Poised for a Turnaround After Losing -11.99% in 4 Weeks

The heavy selling pressure might have exhausted for Raymond James Financial (RJF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

RJFPositive Net Change

Zacks Equity Research

Down -18.04% in 4 Weeks, Here's Why Fiverr (FVRR) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Fiverr (FVRR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

FVRRPositive Net Change

Zacks Equity Research

Down -16.01% in 4 Weeks, Here's Why You Should You Buy the Dip in Paypal (PYPL)

Paypal (PYPL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PYPLPositive Net Change

Zacks Equity Research

PAR Technology (PAR) Loses -15.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PAR Technology (PAR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PARPositive Net Change

Zacks Equity Research

Target Hospitality (TH) Loses -41.46% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Target Hospitality (TH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

THPositive Net Change

Zacks Equity Research

C4 Therapeutics (CCCC) Loses -23.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for C4 Therapeutics (CCCC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CCCCPositive Net Change

Zacks Equity Research

Here's Why Astera Labs, Inc. (ALAB) is Poised for a Turnaround After Losing -13.27% in 4 Weeks

The heavy selling pressure might have exhausted for Astera Labs, Inc. (ALAB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ALABPositive Net Change

Zacks Equity Research

Down -16.99% in 4 Weeks, Here's Why Trex (TREX) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Trex (TREX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

TREXPositive Net Change

Zacks Equity Research

Down -9.31% in 4 Weeks, Here's Why You Should You Buy the Dip in Axos Financial (AX)

The heavy selling pressure might have exhausted for Axos Financial (AX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

AXPositive Net Change

Zacks Equity Research

After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CLBTPositive Net Change